From antigenic drift to algorithmic prediction: Emerging paradigms in influenza vaccine design and global effectiveness (Review)

No authors listed. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 48:1–28. 1999.PubMed/NCBI

Mancini P, Brandtner D, Veneri C, Bonanno Ferraro G, Iaconelli M, Puzelli S, Facchini M, Di Mario G, Stefanelli P, Lucentini L, et al: Evaluation of trends in influenza A and B viruses in wastewater and human surveillance data: Insights from the 2022-2023 season in Italy. Food Environ Virol. 17(6)2024.PubMed/NCBI View Article : Google Scholar

Weinberger DM, Harboe ZB, Viboud C, Krause TG, Miller M, Mølbak K and Konradsen HB: Pneumococcal disease seasonality: Incidence, severity and the role of influenza activity. Eur Respir J. 43:833–841. 2014.PubMed/NCBI View Article : Google Scholar

Owuor DC, de Laurent ZR, Nyawanda BO, Emukule GO, Kondor R, Barnes JR, Nokes DJ, Agoti CN and Chaves SS: Genetic and potential antigenic evolution of influenza A (H1N1)pdm09 viruses circulating in Kenya during 2009-2018 influenza seasons. Sci Rep. 13(22342)2023.PubMed/NCBI View Article : Google Scholar

Wang X, Kulkarni D, Dozier M, Hartnup K, Paget J, Campbell H and Nair H: Usher Network for COVID-19 Evidence Reviews (UNCOVER) group. Influenza vaccination strategies for 2020-21 in the context of COVID-19. J Glob Health. 10(020310)2020.PubMed/NCBI View Article : Google Scholar

Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR and Talbot HK: Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023-24 Influenza Season. MMWR Recomm Rep 72 (No. RR-2):1-25, 2023. DOI: http://dx.doi.org/10.15585/mmwr.rr7202a1.

Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, McLean HQ, Belongia EA, et al: Early estimates of seasonal influenza vaccine effectiveness-United States, January 2015. MMWR Morb Mortal Wkly Rep. 64:10–15. 2015.PubMed/NCBI

Huddleston J and Bedford T: Timely vaccine strain selection and genomic surveillance improves evolutionary forecast accuracy of seasonal influenza A/H3N2. medRxiv: doi: 10.1101/2024.09.11.24313489.

Kim H, Webster RG and Webby RJ: Influenza virus: Dealing with a drifting and shifting pathogen. Viral Immunol. 31:174–183. 2018.PubMed/NCBI View Article : Google Scholar

Mosa AI: Antigenic variability. Front Immunol. 11(2057)2020.PubMed/NCBI View Article : Google Scholar

Tricco AC, Chit A, Soobiah C, Hallett D, Meier G, Chen MH, Tashkandi M, Bauch CT and Loeb M: Comparing influenza vaccine efficacy against mismatched and matched strains: A systematic review and meta-analysis. BMC Med. 11(153)2013.PubMed/NCBI View Article : Google Scholar

Trombetta CM, Kistner O, Montomoli E, Viviani S and Marchi S: Influenza viruses and vaccines: The role of vaccine effectiveness studies for evaluation of the benefits of influenza vaccines. Vaccines (Basel). 10(714)2022.PubMed/NCBI View Article : Google Scholar

Xie H, Wan XF, Ye Z, Plant EP, Zhao Y, Xu Y, Li X, Finch C, Zhao N, Kawano T, et al: H3N2 mismatch of 2014-15 Northern hemisphere influenza vaccines and head-to-head comparison between human and ferret antisera derived antigenic maps. Sci Rep. 5(15279)2015.PubMed/NCBI View Article : Google Scholar

Steel J and Lowen AC: Influenza A virus reassortment. Curr Top Microbiol Immunol. 385:377–401. 2014.PubMed/NCBI View Article : Google Scholar

Harrington WN, Kackos CM and Webby RJ: The evolution and future of influenza pandemic preparedness. Exp Mol Med. 53:737–749. 2021.PubMed/NCBI View Article : Google Scholar

Amorij JP, Huckriede A, Wilschut J, Frijlink HW and Hinrichs WL: Development of stable influenza vaccine powder formulations: Challenges and possibilities. Pharm Res. 25:1256–1273. 2008.PubMed/NCBI View Article : Google Scholar

Wolk DM, Lanyado A, Tice AM, SherMohammed M, Kinar Y, Goren A, Chabris CF, Meyer MN, Shoshan A and Abedi V: Prediction of influenza complications: development and validation of a machine learning prediction model to improve and expand the identification of vaccine-hesitant patients at risk of severe influenza complications. J Clin Med. 11(4342)2022.PubMed/NCBI View Article : Google Scholar

Sparrow E, Wood JG, Chadwick C, Newall AT, Torvaldsen S, Moen A and Torelli G: Global production capacity of seasonal and pandemic influenza vaccines in 2019. Vaccine. 39:512–520. 2021.PubMed/NCBI View Article : Google Scholar

Carregaro RL, Roscani ANCP, Raimundo ACS, Ferreira L, Vanni T, Da Graça Salomão M, Probst LF and Viscondi JYK: Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews. BMC Infect Dis. 23(563)2023.PubMed/NCBI View Article : Google Scholar

Osterhaus A, Fouchier R and Rimmelzwaan G: Towards universal influenza vaccines? Philos Trans R Soc Lond B Biol Sci. 366:2766–2773. 2011.PubMed/NCBI View Article : Google Scholar

Wang Y, Tang CY and Wan XF: Antigenic characterization of influenza and SARS-CoV-2 viruses. Anal Bioanal Chem. 414:2841–2881. 2022.PubMed/NCBI View Article : Google Scholar

Lord JM: The effect of aging of the immune system on vaccination responses. Hum Vaccin Immunother. 9:1364–1367. 2013.PubMed/NCBI View Article : Google Scholar

Dhakal S and Klein SL: Host factors impact vaccine efficacy: Implications for seasonal and universal influenza vaccine programs. J Virol. 93:e00797–19. 2019.PubMed/NCBI View Article : Google Scholar

Henry C, Palm AK, Krammer F and Wilson PC: From original antigenic sin to the universal influenza virus vaccine. Trends Immunol. 39:70–79. 2018.PubMed/NCBI View Article : Google Scholar

Nafziger AN and Pratt DS: Seasonal influenza vaccination and technologies. J Clin Pharmacol. 54:719–731. 2014.PubMed/NCBI View Article : Google Scholar

Petrova VN and Russell CA: The evolution of seasonal influenza viruses. Nat Rev Microbiol. 16:47–60. 2018.PubMed/NCBI View Article : Google Scholar

Gaymard A, Le Briand N, Frobert E, Lina B and Escuret V: Functional balance between neuraminidase and haemagglutinin in influenza viruses. Clin Microbiol Infect. 22:975–983. 2016.PubMed/NCBI View Article : Google Scholar

De Vries E, Du W, Guo H and de Haan CAM: Influenza A virus hemagglutinin-neuraminidase-receptor balance: preserving virus motility. Trends Microbiol. 28:57–67. 2020.PubMed/NCBI View Article : Google Scholar

Xu R and Wilson IA: Structural characterization of an early fusion intermediate of influenza virus hemagglutinin. J Virol. 85:5172–5182. 2011.PubMed/NCBI View Article : Google Scholar

Swanson N: Characterization of in vitro fitness and antigenic drift differences between circulating H1N1 influenza clades (unpublished thesis). Johns Hopkins University, 2024.

Qiu Y, Stegalkina S, Zhang J, Boudanova E, Park A, Zhou Y, Prabakaran P, Pougatcheva S, Ustyugova IV, Vogel TU, et al: Mapping of a novel H3-specific broadly neutralizing monoclonal antibody targeting the hemagglutinin globular head isolated from an elite influenza virus-immunized donor exhibiting serological breadth. J Virol. 94:e01035–19. 2020.PubMed/NCBI View Article : Google Scholar

Tsuchiya E, Sugawara K, Hongo S, Matsuzaki Y, Muraki Y, Li ZN and Nakamura K: Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus. J Gen Virol. 82 (Pt 10):2475–2484. 2001.PubMed/NCBI View Article : Google Scholar

Wiley DC, Wilson IA and Skehel JJ: Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature. 289:373–378. 1981.PubMed/NCBI View Article : Google Scholar

Gerhard W, Yewdell J, Frankel ME and Webster R: Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature. 290:713–717. 1981.PubMed/NCBI View Article : Google Scholar

Baxter D: Evaluating the case for trivalent or quadrivalent influenza vaccines. Hum Vaccin Immunother. 12:2712–2717. 2016.PubMed/NCBI View Article : Google Scholar

Daniels RS and McCauley JW: The health of influenza surveillance and pandemic preparedness in the wake of the COVID-19 pandemic. J Gen Virol. 104(001822)2023.PubMed/NCBI View Article : Google Scholar

World Health Organization (WHO): Sixth Meeting of National Influenza Centres and Influenza Surveillance in the Western Pacific and South-East Asia Regions, Hanoi, Viet Nam, 29-31 May 2012: Meeting report. WHO, Geneva, 2012.

Sánchez de Prada L: Humoral immune response after seasonal influenza vaccination (unpublished thesis). University of Valladolid, 2023.

Graham BS: Advances in antiviral vaccine development. Immunol Rev. 255:230–242. 2013.PubMed/NCBI View Article : Google Scholar

Altman MO, Angeletti D and Yewdell JW: Antibody immunodominance: The key to understanding influenza virus antigenic drift. Viral Immunol. 31:142–149. 2018.PubMed/NCBI View Article : Google Scholar

Tjärnhage E: Exploring the field of respiratory virus preventions: How to deal with future pandemics (unpublished thesis). University of Oslo, 2024.

Dunning J, Thwaites RS and Openshaw PJM: Seasonal and pandemic influenza: 100 years of progress, still much to learn. Mucosal Immunol. 13:566–573. 2020.PubMed/NCBI View Article : Google Scholar

Volz EM, Koelle K and Bedford T: Viral phylodynamics. PLoS Comput Biol. 9(e1002947)2013.PubMed/NCBI View Article : Google Scholar

White MC and Lowen AC: Implications of segment mismatch for influenza A virus evolution. J Gen Virol. 99:3–16. 2018.PubMed/NCBI View Article : Google Scholar

Yong OX: Epidemiological and evolutionary dynamics of influenza B viruses in Kuala Lumpur, Malaysia between 2012 and 2014. MSc thesis, University of Malaya, 2016.

Holmes EC, Ghedin E, Miller N, Taylor J, Bao Y, St George K, Grenfell BT, Salzberg SL, Fraser CM, Lipman DJ and Taubenberger JK: Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol. 3(e300)2005.PubMed/NCBI View Article : Google Scholar

Nelson MI, Viboud C, Simonsen L, Bennett RT, Griesemer SB, St George K, Taylor J, Spiro DJ, Sengamalay NA, Ghedin E, et al: Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog. 4(e1000012)2008.PubMed/NCBI View Article : Google Scholar

Ellis JS, Alvarez-Aguero A, Gregory V, Lin YP, Hay A and Zambon MC: Influenza A H1N2 viruses, United Kingdom, 2001-02 influenza season. Emerg Infect Dis. 9:304–310. 2003.PubMed/NCBI View Article : Google Scholar

Hsieh YH, Huang HM and Lan YC: On temporal patterns and circulation of influenza virus strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 pandemic. PLoS One. 11(e0154695)2016.PubMed/NCBI View Article : Google Scholar

Xu X, Smith CB, Mungall BA, Lindstrom SE, Hall HE, Subbarao K, Cox NJ and Klimov A: Intercontinental circulation of human influenza A (H1N2) reassortant viruses during the 2001-2002 influenza season. J Infect Dis. 186:1490–1493. 2002.PubMed/NCBI View Article : Google Scholar

Wong SS and Webby RJ: Traditional and new influenza vaccines. Clin Microbiol Rev. 26:476–492. 2013.PubMed/NCBI View Article : Google Scholar

Eichelberger MC and Monto AS: Neuraminidase, the forgotten surface antigen, emerges as an influenza vaccine target for broadened protection. J Infect Dis. 219 (Suppl 1):S75–S80. 2019.PubMed/NCBI View Article : Google Scholar

Shoham D: The modes of evolutionary emergence of primal and late pandemic influenza virus strains from viral reservoir in animals: An interdisciplinary analysis. Influenza Res Treat. 2011(861792)2011.PubMed/NCBI View Article : Google Scholar

Van Reeth K and Vincent AL: Influenza viruses. In: Diseases of Swine. 10th edition. Wiley-Blackwell, Hoboken, NJ, pp576-593, 2019.

Webster RG: Antigenic variation in influenza viruses. In: Origin and Evolution of Viruses. Elsevier, pp377-401, 1999.

Gatherer D: The 2009 H1N1 influenza outbreak in its historical context. J Clin Virol. 45:174–178. 2009.PubMed/NCBI View Article : Google Scholar

Bush RM and Cox NJ: Influenza evolution. In: Infectious Disease and Host-Pathogen Evolution. Dronamraju KR (ed). Cambridge University Press, pp175-197, 2004.

Patriarca PA and Cox NJ: Influenza pandemic preparedness plan for the United States. J Infect Dis. 176 (Suppl 1):S4–S7. 1997.PubMed/NCBI View Article : Google Scholar

Chen L, Shao C, Li J and Zhu F: Impact of immunosenescence on vaccine immune responses and countermeasures. Vaccines (Basel). 12(1289)2024.PubMed/NCBI View Article : Google Scholar

Frasca D, Blomberg BB, Garcia D, Keilich SR and Haynes L: Age-related factors that affect B cell responses to vaccination in mice and humans. Immunol Rev. 296:142–154. 2020.PubMed/NCBI View Article : Google Scholar

Gustafson CE, Kim C, Weyand CM and Goronzy JJ: Influence of immune aging on vaccine responses. J Allergy Clin Immunol. 145:1309–1321. 2020.PubMed/NCBI View Article : Google Scholar

Dugan HL, Henry C and Wilson PC: Aging and influenza vaccine-induced immunity. Cell Immunol. 348(103998)2020.PubMed/NCBI View Article : Google Scholar

Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino CM, Ligotti ME, Zareian N and Accardi G: Immunosenescence and its hallmarks: How to oppose aging strategically? A review of potential options for therapeutic intervention. Front Immunol. 10(2247)2019.PubMed/NCBI View Article : Google Scholar

Müller L, Andrée M, Moskorsz W, Drexler I, Walotka L, Grothmann R, Ptok J, Hillebrandt J, Ritchie A, Rabl D, et al: Age-dependent immune response to the Biontech/Pfizer BNT162b2 coronavirus disease 2019 vaccination. Clin Infect Dis. 73:2065–2072. 2021.PubMed/NCBI View Article : Google Scholar

Mosterín Höpping A, McElhaney J, Fonville JM, Powers DC, Beyer WEP and Smith DJ: The confounded effects of age and exposure history in response to influenza vaccination. Vaccine. 34:540–546. 2016.PubMed/NCBI View Article : Google Scholar

Saurwein-Teissl M, Lung TL, Marx F, Gschoesser C, Asch E, Blasko I, Parson W, Böck G, Schönitzer D, Trannoy E and Grubeck-Loebenstein B: Lack of antibody production following immunization in old age: Association with CD8(+)CD28(−) T cell clonal expansions and imbalance in Th1/Th2 cytokine production. J Immunol. 168:5893–5899. 2002.PubMed/NCBI View Article : Google Scholar

Ciabattini A, Nardini C, Santoro F, Garagnani P, Franceschi C and Medaglini D: Vaccination in the elderly: The challenge of immune changes with aging. Semin Immunol. 40:83–94. 2018.PubMed/NCBI View Article : Google Scholar

Nikolich-Žugich J: Aging of the T cell compartment in mice and humans: From no naive expectations to foggy memories. J Immunol. 193:2622–2629. 2014.PubMed/NCBI View Article : Google Scholar

Barbouti A, Vasileiou PVS, Evangelou K, Vlasis KG, Papoudou-Bai A, Gorgoulis VG and Kanavaros P: Implications of oxidative stress and cellular senescence in age-related thymus involution. Oxid Med Cell Longev. 2020(7986071)2020.PubMed/NCBI View Article : Google Scholar

Fink PJ: The biology of recent thymic emigrants. Annu Rev Immunol. 31:31–50. 2013.PubMed/NCBI View Article : Google Scholar

Ruf BR and Knuf M: The burden of seasonal and pandemic influenza in infants and children. Eur J Pediatr. 173:265–276. 2014.PubMed/NCBI View Article : Google Scholar

Sakala IG, Eichinger KM and Petrovsky N: Neonatal vaccine effectiveness and the role of adjuvants. Expert Rev Clin Immunol. 15:869–878. 2019.PubMed/NCBI View Article : Google Scholar

Rudd BD: Neonatal T cells: A reinterpretation. Annu Rev Immunol. 38:229–247. 2020.PubMed/NCBI View Article : Google Scholar

Zhang X, Zhivaki D and Lo-Man R: Unique aspects of the perinatal immune system. Nat Rev Immunol. 17:495–507. 2017.PubMed/NCBI View Article : Google Scholar

Andrew MK, Pott H, Staadegaard L, Paget J, Chaves SS, Ortiz JR, McCauley J, Bresee J, Nunes MC, Baumeister E, et al: Age differences in comorbidities, presenting symptoms, and outcomes of influenza illness requiring hospitalization: A worldwide perspective from the global influenza hospital surveillance network. Open Forum Infect Dis. 10(ofad244)2023.PubMed/NCBI View Article : Google Scholar

Magyari M and Sorensen PS: Comorbidity in multiple sclerosis. Front Neurol. 11(851)2020.PubMed/NCBI View Article : Google Scholar

Xu Q, Wei H, Wen S, Chen J, Lei Y, Cheng Y, Huang W, Wang D and Shu Y: Factors affecting the immunogenicity of influenza vaccines in humans. BMC Infect Dis. 23(211)2023.PubMed/NCBI View Article : Google Scholar

Prendecki M, Clarke C, Brown J, Cox A, Gleeson S, Guckian M, Randell P, Pria AD, Lightstone L, Xu XN, et al: Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine. Lancet. 397:1178–1181. 2021.PubMed/NCBI View Article : Google Scholar

Kwetkat A and Heppner HJ: Comorbidities in the elderly and their possible influence on vaccine response. Interdiscip Top Gerontol Geriatr. 43:73–85. 2020.PubMed/NCBI View Article : Google Scholar

Li Y, Cao GY, Jing WZ, Liu J and Liu M: Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990-2019: Findings from the 2019 global burden of disease study. Eur J Prev Cardiol. 30:276–286. 2023.PubMed/NCBI View Article : Google Scholar

Frasca D and Blomberg BB: B cell function and influenza vaccine responses in healthy aging and disease. Curr Opin Immunol. 29:112–118. 2014.PubMed/NCBI View Article : Google Scholar

Werba JP, Veglia F, Amato M, Baldassarre D, Massironi P, Meroni PL, Riboldi P, Tremoli E and Camera M: Patients with a history of stable or unstable coronary heart disease have different acute phase responses to an inflammatory stimulus. Atherosclerosis. 196:835–840. 2008.PubMed/NCBI View Article : Google Scholar

Callahan ST, Wolff M, Hill HR and Edwards KM: NIAID Vaccine and Treatment Evaluation Unit (VTEU) Pandemic H1N1 Vaccine Study Group. Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults. J Infect Dis. 210:1270–1274. 2014.PubMed/NCBI View Article : Google Scholar

Honce R and Schultz-Cherry S: Impact of obesity on influenza A virus pathogenesis, immune response, and evolution. Front Immunol. 10(1071)2019.PubMed/NCBI View Article : Google Scholar

Harris JA, Moniz MH, Iott B, Power R and Griggs JJ: Obesity and the receipt of influenza and pneumococcal vaccination: A systematic review and meta-analysis. BMC Obes. 3(24)2016.PubMed/NCBI View Article : Google Scholar

Sherman AC, Lai L, Bower M, Natrajan MS, Huerta C, Karmali V, Kleinhens J, Xu Y, Rouphael N and Mulligan MJ: The effects of imprinting and repeated seasonal influenza vaccination on adaptive immunity after influenza vaccination. Vaccines (Basel). 8(663)2020.PubMed/NCBI View Article : Google Scholar

Cobey S and Hensley SE: Immune history and influenza virus susceptibility. Curr Opin Virol. 22:105–111. 2017.PubMed/NCBI View Article : Google Scholar

Jang H and Ross TM: Preexisting influenza-specific immunity and vaccine effectiveness. Expert Rev Vaccines. 18:1043–1051. 2019.PubMed/NCBI View Article : Google Scholar

McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich TC and Belongia EA: Impact of repeated vaccination on vaccine effectiveness against influenza A (H3N2) and B during 8 seasons. Clin Infect Dis. 59:1375–1385. 2014.PubMed/NCBI View Article : Google Scholar

Bartoszko JJ, McNamara IF, Aras OAZ, Hylton DA, Zhang YB, Malhotra D, Hyett SL, Morassut RE, Rudziak P and Loeb M: Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis. Vaccine. 36:3434–3444. 2018.PubMed/NCBI View Article : Google Scholar

Zelner J, Petrie JG, Trangucci R, Martin ET and Monto AS: Effects of sequential influenza A (H1N1)pdm09 vaccination on antibody waning. J Infect Dis. 220:12–19. 2019.PubMed/NCBI View Article : Google Scholar

Chen JR, Liu YM, Tseng YC and Ma C: Better influenza vaccines: An industry perspective. J Biomed Sci. 27(33)2020.PubMed/NCBI View Article : Google Scholar

Grohskopf LA, Alyanak E, Broder KR, Blanton LH, Fry AM, Jernigan DB and Atmar RL: Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2020-21 influenza season. MMWR Recomm Rep. 69:1–24. 2020.PubMed/NCBI View Article : Google Scholar

Rolfes MA, Flannery B, Chung JR, O'Halloran A, Garg S, Belongia EA, Gaglani M, Zimmerman RK, Jackson ML, Monto AS, et al: Effects of influenza vaccination in the United States during the 2017-2018 influenza season. Clin Infect Dis. 69:1845–1853. 2019.PubMed/NCBI View Article : Google Scholar

McElhaney JE, Kuchel GA, Zhou X, Swain SL and Haynes L: T-cell immunity to influenza in older adults: A pathophysiological framework for development of more effective vaccines. Front Immunol. 7(41)2016.PubMed/NCBI View Article : Google Scholar

Janssens Y, Joye J, Waerlop G, Clement F, Leroux-Roels G and Leroux-Roels I: The role of cell-mediated immunity against influenza and its implications for vaccine evaluation. Front Immunol. 13(959379)2022.PubMed/NCBI View Article : Google Scholar

Tsang TK, Lam KT, Liu Y, Fang VJ, Mu X, Leung NHL, Peiris JM, Leung GM, Cowling BJ and Tu W: Investigation of CD4 and CD8 T cell-mediated protection against influenza A virus in a cohort study. BMC Med. 20(230)2022.PubMed/NCBI View Article : Google Scholar

L'Huillier AG, Ferreira VH, Hirzel C, Nellimarla S, Ku T, Natori Y, Humar A and Kumar D: T-cell responses following natural influenza infection or vaccination in solid organ transplant recipients. Sci Rep. 10(10104)2020.PubMed/NCBI View Article : Google Scholar

Velasco-Medina AA, García-León ML, Velázquez-Sámano G and Wong-Chew RM: The cellular and humoral immune response to influenza vaccination is comparable in asthmatic and healthy subjects. Hum Vaccin Immunother. 17:98–105. 2021.PubMed/NCBI View Article : Google Scholar

Rosendahl Huber SK, Hendriks M, Jacobi RHJ, van de Kassteele J, Mandersloot-Oskam JC, van Boxtel RAJ, Wensing AMJ, Rots NY, Luytjes W and van Beek J: Immunogenicity of influenza vaccines: Evidence for differential effect of secondary vaccination on humoral and cellular immunity. Front Immunol. 9(3103)2019.PubMed/NCBI View Article : Google Scholar

Quiñones-Parra S, Loh L, Brown LE, Kedzierska K and Valkenburg SA: Universal immunity to influenza must outwit immune evasion. Front Microbiol. 5(285)2014.PubMed/NCBI View Article : Google Scholar

Schmolke M and García-Sastre A: Evasion of innate and adaptive immune responses by influenza A virus. Cell Microbiol. 12:873–880. 2010.PubMed/NCBI View Article : Google Scholar

Rashid F, Xie Z, Li M, Xie Z, Luo S and Xie L: Roles and functions of IAV proteins in host immune evasion. Front Immunol. 14(1323560)2023.PubMed/NCBI View Article : Google Scholar

Hale BG, Albrecht RA and García-Sastre A: Innate immune evasion strategies of influenza viruses. Future Microbiol. 5:23–41. 2010.PubMed/NCBI View Article : Google Scholar

Van de Sandt CE, Kreijtz JH and Rimmelzwaan GF: Evasion of influenza A viruses from innate and adaptive immune responses. Viruses. 4:1438–1476. 2012.PubMed/NCBI View Article : Google Scholar

Hsu ACY: Influenza virus: A master tactician in innate immune evasion and novel therapeutic interventions. Front Immunol. 9(743)2018.PubMed/NCBI View Article : Google Scholar

Kim P, Jang YH, Kwon SB, Lee CM, Han G and Seong BL: Glycosylation of hemagglutinin and neuraminidase of influenza A virus as signature for ecological spillover and adaptation among influenza reservoirs. Viruses. 10(183)2018.PubMed/NCBI View Article : Google Scholar

Su G, Chen Y, Li X and Shao JW: Virus versus host: Influenza A virus circumvents the immune responses. Front Microbiol. 15(1394510)2024.PubMed/NCBI View Article : Google Scholar

Zhao T, Cai Y, Jiang Y, He X, Wei Y, Yu Y and Tian X: Vaccine adjuvants: mechanisms and platforms. Signal Transduct Target Ther. 8(283)2023.PubMed/NCBI View Article : Google Scholar

Shichinohe S and Watanabe T: Advances in adjuvanted influenza vaccines. Vaccines (Basel). 11(1391)2023.PubMed/NCBI View Article : Google Scholar

Facciolà A, Visalli G, Laganà A and Di Pietro A: An overview of vaccine adjuvants: Current evidence and future perspectives. Vaccines (Basel). 10(819)2022.PubMed/NCBI View Article : Google Scholar

Li Z, Zhao Y, Li Y and Chen X: Adjuvantation of influenza vaccines to induce cross-protective immunity. Vaccines (Basel). 9(75)2021.PubMed/NCBI View Article : Google Scholar

Chan L, Alizadeh K, Alizadeh K, Fazel F, Kakish JE, Karimi N, Knapp JP, Mehrani Y, Minott JA, Morovati S, et al: Review of influenza virus vaccines: the qualitative nature of immune responses to infection and vaccination is a critical consideration. Vaccines (Basel). 9(979)2021.PubMed/NCBI View Article : Google Scholar

Zanobini P, Bonaccorsi G, Lorini C, Haag M, McGovern I, Paget J and Caini S: Global patterns of seasonal influenza activity, duration of activity and virus (sub)type circulation from 2010 to 2020. Influenza Other Respir Viruses. 16:696–706. 2022.PubMed/NCBI View Article : Google Scholar

Yadegari I, Omidi M and Smith SR: The herd-immunity threshold must be updated for multi-vaccine strategies and multiple variants. Sci Rep. 11(22970)2021.PubMed/NCBI View Article : Google Scholar

Plans-Rubió P: The vaccination coverage required to establish herd immunity against influenza viruses. Prev Med. 55:72–77. 2012.PubMed/NCBI View Article : Google Scholar

Jung H and Albarracín D: Concerns for others increase the likelihood of vaccination against influenza and COVID-19 more in sparsely rather than densely populated areas. Proc Natl Acad Sci USA. 118(e2007538118)2021.PubMed/NCBI View Article : Google Scholar

Böhm R and Betsch C: Prosocial vaccination. Curr Opin Psychol. 43:307–311. 2022.PubMed/NCBI View Article : Google Scholar

Al-Hasan A, Khuntia J and Yim D: Does seeing what others do through social media influence vaccine uptake and help in the herd immunity through vaccination? A cross-sectional analysis. Front Public Health. 9(715931)2021.PubMed/NCBI View Article : Google Scholar

Froes F, Timóteo A, Almeida B, Raposo JF, Oliveira J, Carrageta M, Duque S and Morais A: Influenza vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Society of Cardiology, the Portuguese Society of Diabetology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Geriatrics and Gerontology, and the Study Group of Geriatrics of the Portuguese Society of Internal Medicine. Pulmonology. 30:422–436. 2024.PubMed/NCBI View Article : Google Scholar

Lutz CS, Biggerstaff M, Rolfes MA, Lafond KE, Azziz-Baumgartner E, Porter RM, Reed C and Bresee JS: Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low-and middle-income countries. Vaccine. 39:4219–4230. 2021.PubMed/NCBI View Article : Google Scholar

Stuurman AL, Rizzo C and Haag M: Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe. PLoS One. 16(e0248943)2021.PubMed/NCBI View Article : Google Scholar

Dhar R, Ghoshal AG, Guleria R, Sharma S, Kulkarni T, Swarnakar R, Samaria JK, Chaudhary S, Gaur SN, Christopher DJ, et al: Clinical practice guidelines 2019: Indian consensus-based recommendations on influenza vaccination in adults. Lung India. 37 (Supplement):S4–S18. 2020.PubMed/NCBI View Article : Google Scholar

Igboh LS, Roguski K, Marcenac P, Emukule GO, Charles MD, Tempia S, Herring B, Vandemaele K, Moen A, Olsen SJ, et al: Timing of seasonal influenza epidemics for 25 countries in Africa during 2010-19: A retrospective analysis. Lancet Glob Health. 11:e729–e739. 2023.PubMed/NCBI View Article : Google Scholar

Yoon D, Kim JH, Lee H and Shin JY: Updates on vaccine safety and post-licensure surveillance for adverse events following immunization in South Korea, 2005-2017. Yonsei Med J. 61:623–630. 2020.PubMed/NCBI View Article : Google Scholar

Cuschieri S and Grech V: A comparative assessment of attitudes and hesitancy for influenza vis-à-vis COVID-19 vaccination among healthcare students and professionals in Malta. Z Gesundh Wiss. 30:2441–2448. 2022.PubMed/NCBI View Article : Google Scholar

Wang SY, Pan XJ, Deng X, Zhang HJ and Chen ZP: An exploratory framework of vaccine hesitancy monitoring and early warning system in China. Zhonghua Yu Fang Yi Xue Za Zhi. 55:925–930. 2021.PubMed/NCBI View Article : Google Scholar : (In Chinese).

Lim CML, Komarasamy TV, Adnan NAAB, Radhakrishnan AK and Balasubramaniam VR: Recent advances, approaches and challenges in the development of universal influenza vaccines. Influenza Other Respir Viruses. 18(e13276)2024.PubMed/NCBI View Article : Google Scholar

World Health Organization (WHO): SAGE working group on vaccine hesitancy: Report. WHO, Geneva, 2024. https://www.who.int/docs/default-source/immunization/sage/2014/october/sage-working-group-revised-report-vaccine-hesitancy.pdf.

Osterholm MT, Kelley NS, Sommer A and Belongia EA: Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis. Lancet Infect Dis. 12:36–44. 2012.PubMed/NCBI View Article : Google Scholar

Bullard BL and Weaver EA: Strategies targeting hemagglutinin as a universal influenza vaccine. Vaccines (Basel). 9(257)2021.PubMed/NCBI View Article : Google Scholar

Mader K and Dustin LB: Beyond bNAbs: Uses, risks, and opportunities for therapeutic application of non-neutralising antibodies in viral infection. Antibodies (Basel). 13(28)2024.PubMed/NCBI View Article : Google Scholar

Fu Y, Zhang Z, Sheehan J, Avnir Y, Ridenour C, Sachnik T, Sun J, Hossain MJ, Chen LM, Zhu Q, et al: A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve. Nat Commun. 7(12780)2016.PubMed/NCBI View Article : Google Scholar

Krammer F, Palese P and Steel J: Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. Curr Top Microbiol Immunol. 386:301–321. 2015.PubMed/NCBI View Article : Google Scholar

Aartse A, Mortier D, Mooij P, Hofman S, van Haaren MM, Corcoran M, Karlsson Hedestam GB, Eggink D, Claireaux M, Bogers WMJM, et al: Primary antibody response after influenza virus infection is first dominated by low-mutated HA-stem antibodies followed by higher-mutated HA-head antibodies. Front Immunol. 13(1026951)2022.PubMed/NCBI View Article : Google Scholar

Qiu X, Duvvuri VR and Bahl J: Computational approaches and challenges to developing universal influenza vaccines. Vaccines (Basel). 7(45)2019.PubMed/NCBI View Article : Google Scholar

Jackson NAC, Kester KE, Casimiro D, Gurunathan S and DeRosa F: The promise of mRNA vaccines: A biotech and industrial perspective. NPJ Vaccines. 5(11)2020.PubMed/NCBI View Article : Google Scholar

Petsch B, Schnee M, Vogel AB, Lange E, Hoffmann B, Voss D, Schlake T, Thess A, Kallen KJ, Stitz L, et al: Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection. Nat Biotechnol. 30:1210–1216. 2012.PubMed/NCBI View Article : Google Scholar

Park HJ, Bang YJ, Kwon SP, Kwak W, Park SI, Roh G, Bae SH, Kim JY, Kwak HW, Kim Y, et al: Analyzing immune responses to varied mRNA and protein vaccine sequences. NPJ Vaccines. 8(84)2023.PubMed/NCBI View Article : Google Scholar

Huang J, Yuen D, Mintern JD and Johnston AP: Opportunities for innovation: Building on the success of lipid nanoparticle vaccines. Curr Opin Colloid Interface Sci. 55(101468)2021.PubMed/NCBI View Article : Google Scholar

Teng M, Yao Y, Nair V and Luo J: Latest advances of virology research using CRISPR/Cas9-based gene-editing technology and its application to vaccine development. Viruses. 13(779)2021.PubMed/NCBI View Article : Google Scholar

Al Fayez N, Nassar MS, Alshehri AA, Alnefaie MK, Almughem FA, Alshehri BY, Alawad AO and Tawfik EA: Recent advancement in mRNA vaccine development and applications. Pharmaceutics. 15(1972)2023.PubMed/NCBI View Article : Google Scholar

Chauhan RP and Gordon ML: Review of genome sequencing technologies in molecular characterization of influenza A viruses in swine. J Vet Diagn Invest. 34:177–189. 2022.PubMed/NCBI View Article : Google Scholar

Gong X, Hu M, Chen W, Yang H, Wang B, Yue J, Jin Y, Liang L and Ren H: Reassortment network of influenza A virus. Front Microbiol. 12(793500)2021.PubMed/NCBI View Article : Google Scholar

Zhao AP, Li S, Cao Z, Hu PJH, Wang J, Xiang Y, Xie D and Lu X: AI for science: predicting infectious diseases. J Saf Sci Resil. 5:130–146. 2024.

Danchin A: Artificial intelligence-based prediction of pathogen emergence and evolution in the world of synthetic biology. Microb Biotechnol. 17(e70014)2024.PubMed/NCBI View Article : Google Scholar

Mohamed T, Sayed S, Salah A and Houssein EH: Deep neural network for virus mutation prediction: A comprehensive review. In: Integrating Meta-Heuristics and Machine Learning for Real-World Optimization Problems. Studies in Computational Intelligence. Houssein EH, Abd Elaziz M, Oliva D and Abualigah L (eds). Vol 1038. Springer, Cham, 2022.

Gong M, Liu L, Sun X, Yang Y, Wang S and Zhu H: Cloud-based system for effective surveillance and control of COVID-19: useful experiences from Hubei, China. J Med Internet Res. 22(e18948)2020.PubMed/NCBI View Article : Google Scholar

Mustafa MI and Makhawi AM: SHERLOCK and DETECTR: CRISPR-Cas systems as potential rapid diagnostic tools for emerging infectious diseases. J Clin Microbiol. 59:e00745–20. 2021.PubMed/NCBI View Article : Google Scholar

Kulkarni A, Tanga S, Karmakar A, Hota A and Maji B: CRISPR-based precision molecular diagnostics for disease detection and surveillance. ACS Appl Bio Mater. 6:3927–3945. 2023.PubMed/NCBI View Article : Google Scholar

Umar Ibrahim A, Pwavodi PC, Ozsoz M, Al-Turjman F, Galaya T and Agbo JJ: CRISPR biosensing and AI-driven tools for detection and prediction of COVID-19. J Exp Theor Artif Intell. 35:489–505. 2023.

Rutherford N: The transductive flu: Disruptive virality and biosocial immunity (unpublished thesis). Université d'Ottawa, 2024.

Hannings AN, Darley A, Kearney JC, Upchurch BL and Groft K: Marketing mobile influenza vaccine clinics on a college campus. J Am Pharm Assoc. 62:551–554.e1. 2022.PubMed/NCBI View Article : Google Scholar

Tuckerman J, Kaufman J and Danchin M: Effective approaches to combat vaccine hesitancy. Pediatr Infect Dis J. 41:e243–e245. 2022.PubMed/NCBI View Article : Google Scholar

Steffens MS, Dunn AG, Leask J and Wiley KE: Using social media for vaccination promotion: practices and challenges. Digital Health. 6(2055207620970785)2020.PubMed/NCBI View Article : Google Scholar

Benjamin-Chung J, Arnold BF, Kennedy CJ, Mishra K, Pokpongkiat N, Nguyen A, Jilek W, Holbrook K, Pan E and Kirley PD: Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza: a matched cohort study. PLoS Med. 17(e1003238)2020.PubMed/NCBI View Article : Google Scholar

Gualano MR, Santoro PE, Borrelli I, Rossi MF, Amantea C, Tumminello A, Daniele A, Beccia F and Moscato U: Employee participation in workplace vaccination campaigns: A systematic review and meta-analysis. Vaccines. 10(1898)2022.PubMed/NCBI View Article : Google Scholar

Hill I, Porter Z, Mayer J, Verdeflor A, Brown K and Lawrence D: Building the evidence base for advancing vaccine equity. 2023.

Friede M, Palkonyay L, Alfonso C, Pervikov Y, Torelli G, Wood D and Kieny MP: WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer. Vaccine. 29:A2–A7. 2011.PubMed/NCBI View Article : Google Scholar

World Health Organization (WHO): Influenza (avian and other zoonotic). WHO, Geneva, 2026. https://www.who.int/news-room/fact-sheets/detail/influenza-%28avian-and-other-zoonotic%29. Accessed March 5, 2026.

Centers for Disease Control and Prevention (CDC): 1957-1958 pandemic (H2N2 virus). CDC, Atlanta, GA, 2019. https://archive.cdc.gov/www_cdc_gov/flu/pandemic-resources/1957-1958-pandemic.html. Accessed March 5, 2026.

Centers for Disease Control and Prevention (CDC): 1968 pandemic (H3N2 virus). CDC, Atlanta, GA, 2019. https://archive.cdc.gov/www_cdc_gov/flu/pandemic-resources/1968-pandemic.html. Accessed March 5, 2026.

Komadina N, McVernon J, Hall R and Leder K: A historical perspective of influenza A(H1N2) virus. Emerg Infect Dis. 20:6–12. 2014.PubMed/NCBI View Article : Google Scholar

Jester BJ, Uyeki TM and Jernigan DB: Fifty years of influenza A(H3N2) following the pandemic of 1968. Am J Public Health. 110:669–676. 2020.PubMed/NCBI View Article : Google Scholar

Centers for Disease Control and Prevention (CDC): Types of influenza viruses. CDC, Atlanta, GA, 2025. https://www.cdc.gov/flu/about/viruses-types.html. Accessed March 5, 2026.

Centers for Disease Control and Prevention (CDC): How flu viruses can change: ‘Drift’ and ‘Shift’. CDC, Atlanta, GA, 2024. https://www.cdc.gov/flu/php/viruses/change.html. Accessed March 5, 2026.

Centers for Disease Control and Prevention (CDC): Understanding influenza viruses. CDC, Atlanta, GA, 2024. https://www.cdc.gov/flu/php/viruses/index.html. Accessed March 5, 2026.

World Health Organization: Global influenza surveillance and response system (GISRS). https://www.who.int/initiatives/global-influenza-surveillance-and-response-system. Accessed March 5, 2026.

World Health Organization (WHO): Recommendations for influenza vaccine composition for the 2026-2027 northern hemisphere season. WHO, Geneva, 2026. https://www.who.int/news/item/27-02-2026-recommendations-for-influenza-vaccine-composition-for-the-2026-2027-northern-hemisphere-season. Accessed March 5, 2026.

World Health Organization (WHO): Recommended composition of influenza virus vaccines for use in the 2026-2027 northern hemisphere influenza season. WHO, Geneva, 2026. https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2026-2027-northern-hemisphere-influenza-season. Accessed March 5, 2026.

World Health Organization (WHO): Questions and answers: Recommended composition of influenza virus vaccines for use in the 2026-2027 northern hemisphere influenza season. WHO, Geneva, 2026. https://cdn.who.int/media/docs/default-source/vcm-northern-hemisphere-recommendation-2026-2027/b.-27-feb-2026-frequently-asked-questions.pdf. Accessed March 5, 2026.

World Health Organization: Global influenza virological surveillance (FluNet/GISRS overview). https://www.who.int/data/gho/data/themes/global-influenza-virological-surveillance. Accessed March 5, 2026.

Hay AJ and McCauley JW: The WHO global influenza surveillance and response system (GISRS)-A future perspective. Influenza Other Respir Viruses. 12:551–557. 2018.PubMed/NCBI View Article : Google Scholar